Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

September 15, 2005 (Vol. 25, No. 16)

Flanders' Biotech Sector Comes of Age

Proven Scientific Expertise and Range of Incentives Drive Growth

  • Two IPOs in May and June 2005 of Belgian biotechs, DevGen (Ghent) and Galapagos Genomics (Mechelen), which raised E30 million and E20 million, respectively, may be considered a bellwether of a rapidly growing Belgian biotech industry. Another sign that the regions biotech industry is reaching critical mass was ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.